Literature DB >> 16951346

Constitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor Sp1.

David M Cauvi1, Gabrielle Cauvi, K Michael Pollard.   

Abstract

The complement regulatory protein decay-accelerating factor (DAF or CD55) protects host tissue from complement-mediated injury by inhibiting the classical and alternative complement pathways. Besides its role in complement regulation, DAF has also been shown to be a key player in T cell immunity. Modulation of DAF expression could therefore represent a critical regulatory mechanism in both innate and adaptive immune responses. To identify and characterize key transcriptional regulatory elements controlling mouse Daf1 expression, a 2.5-kb fragment corresponding to the 5' flanking region of the mouse Daf1 gene was cloned. Sequence analysis showed that the mouse Daf1 promoter lacks conventional TATA and CCAAT boxes and displays a high guanine and cytosine content. RACE was used to identify one major and two minor transcription start sites 47, 20, and 17 bp upstream of the translational codon. Positive and negative regulatory regions were identified by transiently transfecting sequential 5'deletion constructs of the 5'flanking region into NIH/3T3, M12.4, and RAW264.7 cells. Mutational analyses of the promoter region combined with Sp1-specific ELISA showed that the transcription factor Sp1 is required for basal transcription and LPS-induced expression of the Daf1 gene. These findings provide new information on the regulation of the mouse Daf1 promoter and will facilitate further studies on the expression of Daf1 during immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951346      PMCID: PMC1766464          DOI: 10.4049/jimmunol.177.6.3837

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

1.  Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis.

Authors:  Lizette Visser; Alex F de Vos; Jörg Hamann; Marie-José Melief; Marjan van Meurs; René A W van Lier; Jon D Laman; Rogier Q Hintzen
Journal:  J Neuroimmunol       Date:  2002-11       Impact factor: 3.478

Review 2.  Interactions of CD55 with non-complement ligands.

Authors:  S Lea
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

3.  Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells.

Authors:  A Iborra; M Mayorga; N Llobet; P Martínez
Journal:  Cell Immunol       Date:  2003-05       Impact factor: 4.868

4.  The role of Sp1 and NF-kappa B in regulating CD40 gene expression.

Authors:  Masahide Tone; Yukiko Tone; Jennifer M Babik; Chun-Yen Lin; Herman Waldmann
Journal:  J Biol Chem       Date:  2001-12-20       Impact factor: 5.157

5.  Upregulation of DAF (CD55) on orbital fibroblasts by cytokines. Differential effects of TNF-beta and TNF-alpha.

Authors:  E T Cocuzzi; D S Bardenstein; A Stavitsky; N Sundarraj; M E Medof
Journal:  Curr Eye Res       Date:  2001-08       Impact factor: 2.424

6.  Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies.

Authors:  F Lin; Y Fukuoka; A Spicer; R Ohta; N Okada; C L Harris; S N Emancipator; M E Medof
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

7.  Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity.

Authors:  T Miwa; X Sun; R Ohta; N Okada; C L Harris; B P Morgan; W C Song
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

8.  Intestinal trefoil factor induces decay-accelerating factor expression and enhances the protective activities against complement activation in intestinal epithelial cells.

Authors:  A Andoh; K Kinoshita; I Rosenberg; D K Podolsky
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

9.  Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition.

Authors:  Saifur R Ahmad; Elaine A Lidington; Rieko Ohta; Noriko Okada; Michael G Robson; Kevin A Davies; Michael Leitges; Claire L Harris; Dorian O Haskard; Justin C Mason
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

10.  Ensembl 2006.

Authors:  E Birney; D Andrews; M Caccamo; Y Chen; L Clarke; G Coates; T Cox; F Cunningham; V Curwen; T Cutts; T Down; R Durbin; X M Fernandez-Suarez; P Flicek; S Gräf; M Hammond; J Herrero; K Howe; V Iyer; K Jekosch; A Kähäri; A Kasprzyk; D Keefe; F Kokocinski; E Kulesha; D London; I Longden; C Melsopp; P Meidl; B Overduin; A Parker; G Proctor; A Prlic; M Rae; D Rios; S Redmond; M Schuster; I Sealy; S Searle; J Severin; G Slater; D Smedley; J Smith; A Stabenau; J Stalker; S Trevanion; A Ureta-Vidal; J Vogel; S White; C Woodwark; T J P Hubbard
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

View more
  7 in total

1.  Depletion of complement does not impact initiation of xenobiotic-induced autoimmune disease.

Authors:  David M Cauvi; Christopher B Toomey; K Michael Pollard
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

2.  Role of transcription factor Sp1 and RNA binding protein HuR in the downregulation of Dr+ Escherichia coli receptor protein decay accelerating factor (DAF or CD55) by nitric oxide.

Authors:  Manu Banadakoppa; Daniel Liebenthal; David E Nowak; Petri Urvil; Uma Yallampalli; Gerald M Wilson; Aparna Kishor; Chandra Yallampalli
Journal:  FEBS J       Date:  2013-01-02       Impact factor: 5.542

Review 3.  Transcriptional control of complement receptor gene expression.

Authors:  Brian K Martin
Journal:  Immunol Res       Date:  2007       Impact factor: 4.505

Review 4.  Regulation of Complement Activation by Heme Oxygenase-1 (HO-1) in Kidney Injury.

Authors:  Maria G Detsika; Elias A Lianos
Journal:  Antioxidants (Basel)       Date:  2021-01-06

5.  A functional SNP in the regulatory region of the decay-accelerating factor gene associates with extraocular muscle pareses in myasthenia gravis.

Authors:  J M Heckmann; H Uwimpuhwe; R Ballo; M Kaur; V B Bajic; S Prince
Journal:  Genes Immun       Date:  2009-08-13       Impact factor: 2.676

Review 6.  The role of decay accelerating factor in environmentally induced and idiopathic systemic autoimmune disease.

Authors:  Christopher B Toomey; David M Cauvi; Kenneth M Pollard
Journal:  Autoimmune Dis       Date:  2014-01-27

7.  A tandem repeat in decay accelerating factor 1 is associated with severity of murine mercury-induced autoimmunity.

Authors:  David M Cauvi; Rodney Gabriel; Dwight H Kono; Per Hultman; K Michael Pollard
Journal:  Autoimmune Dis       Date:  2014-04-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.